Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CATX will rise by +3.19% over the next 2 Weeks and hit $3.59 by Wednesday, September 2, 2026. In that time frame, CATX's share price is expected to range between $3.46 and $3.71.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 2, 2026 | 3.46 | 3.59 | 3.71 |
| Sep 1, 2026 | 3.40 | 3.53 | 3.66 |
| Aug 31, 2026 | 3.39 | 3.52 | 3.64 |
| Aug 28, 2026 | 3.29 | 3.42 | 3.53 |
| Aug 27, 2026 | 3.33 | 3.44 | 3.55 |
| Aug 26, 2026 | 3.37 | 3.48 | 3.60 |
| Aug 25, 2026 | 3.30 | 3.42 | 3.53 |
| Aug 24, 2026 | 3.30 | 3.41 | 3.53 |
| Aug 21, 2026 | 3.20 | 3.31 | 3.42 |
| Aug 20, 2026 | 3.23 | 3.34 | 3.45 |
CATX shares fell -5.89% in Thursday, August 20, 2026's trading session, dropping from a previous close of $3.48 to move at $3.28. The stock demonstrated notable intraday movement (see CATX's key stats for a full breakdown), fluctuating between $3.28 and $3.47, a +5.95% trading range. While recent weeks have seen some volatility, CATX has managed to secure a +10.27% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.75M shares changing hands, 990.39K more than the previous session. This amounted to $5.73M in total market activity.
Will CATX Continue Its Upward Trend?
According to analyst ratings and projections for CATX, Perspective Therapeutics, Inc. shares are anticipated to increase by +11.82%, potentially reaching $3.71 per share by September 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for CATX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CATX stock forecast, now is a good time to buy CATX stock because its current trading price is -8.80% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CATX covering social and institutional perspectives.
CATX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CATX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.97% to 59.27%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.07%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.86%, maintains a neutral outlook for the long term. Insights into CATX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Perspective Therapeutics Short-Term Forecasts
CATX Forecast For Next 5 Days
Our algorithm anticipates Perspective Therapeutics (CATX) stock could hit $3.62 by Aug 27, 2026. This represents a +10.53% rise from today's price, following a +0.83% change over the past five days.
CATX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Perspective Therapeutics, Inc. (CATX) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.44, which would mean a +5.04% increase from the current price of $3.28. Projections for this period range from a high of $4.11 to a low of $2.80.
CATX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Perspective Therapeutics's price over the next three months point to a rise. CATX stock is expected to peak at $8.49 on Oct 20, 2026 before potentially dipping to $5.39 on Nov 19, 2026. On average, CATX is likely to trade around $7.39 in the coming 90 days.
Perspective Therapeutics Stock Forecast 2025
Based on our predictive models, Perspective Therapeutics (CATX) is expected to trade between $2.75 and $8.49 throughout 2026. This would result in an average price of $6.58, potentially offering investors a +100.92% return from current levels.
Perspective Therapeutics, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Perspective Therapeutics, Inc. (CATX) is positioned to show a strong performance in August 2026. The price is predicted to move between $6.75 and $7.73, settling at an average of $7.25. This could translate to a +121.37% gain.
September 2026
Based on current market signals, Perspective Therapeutics, Inc. is projected to trend september 2026. We forecast a trading range from $6.66 to $8.04, with a likely average price of $7.35. Investors could expect a potential return of +124.43%.
October 2026
Our predictive algorithms indicate Perspective Therapeutics, Inc. stock may see a shift in October 2026. The expected range spans $6.92–$8.49, with an average target of $7.91. This represents a positive outlook and a possible gain of +141.53%.
November 2026
Analyzing established trends, Perspective Therapeutics, Inc. looks set to move in November 2026. Projections place the stock between $4.02 and $7.59, averaging around $6.39. This suggests a +95.11% gain from current levels.
December 2026
Market indicators suggest Perspective Therapeutics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $2.75 to $5.54, with a midpoint forecast of $4.50. The stock might deliver a +37.40% gain.
January 2027
Forecasting for January 2027, models estimate that Perspective Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $3.46 and $6.96, averaging $5.72. This signals a positive trajectory with potential returns around +74.66%.
February 2027
According to our latest forecast models, Perspective Therapeutics, Inc. (CATX) is positioned to show a strong performance in February 2027. The price is predicted to move between $4.06 and $9.30, settling at an average of $8.84. This could translate to a +169.92% gain.
March 2027
Based on current market signals, Perspective Therapeutics, Inc. is projected to trend march 2027. We forecast a trading range from $1.76 to $9.46, with a likely average price of $9.53. Investors could expect a potential return of +190.99%.
April 2027
Our predictive algorithms indicate Perspective Therapeutics, Inc. stock may see a shift in April 2027. The expected range spans $0.00–$8.75, with an average target of $8.70. This represents a positive outlook and a possible gain of +165.65%.
May 2027
Analyzing established trends, Perspective Therapeutics, Inc. looks set to move in May 2027. Projections place the stock between $0.00 and $7.98, averaging around $7.45. This suggests a +127.48% gain from current levels.
June 2027
Market indicators suggest Perspective Therapeutics, Inc. could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $6.01, with a midpoint forecast of $5.35. The stock might deliver a +63.36% gain.
July 2027
Forecasting for July 2027, models estimate that Perspective Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $7.37, averaging $6.52. This signals a positive trajectory with potential returns around +99.08%.
August 2027
According to our latest forecast models, Perspective Therapeutics, Inc. (CATX) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $7.54, settling at an average of $7.09. This could translate to a +116.49% gain.
CATX's history of dividends and stock splits also plays a role in long-term investor confidence.